Office-based treatment of glottal dysplasia and papillomatosis with the 585-nm pulsed dye laser and local anesthesia
- PMID: 15112968
- DOI: 10.1177/000348940411300403
Office-based treatment of glottal dysplasia and papillomatosis with the 585-nm pulsed dye laser and local anesthesia
Abstract
Treatment of glottal papillomatosis and dysplasia was mirror-guided and performed in surgeons' offices in the 19th century. It migrated to the operating room in the 20th century to accommodate direct laryngoscopic surgery, which required assistants to administer anesthesia and procedural support. Presently, the primary treatment goals, which are disease regression and voice restoration or maintenance, are tempered by the morbidity of general anesthesia and potential treatment-induced vocal deterioration. In fact, general anesthesia has been appropriately considered to be an acceptable source of morbidity for the promise of a precise procedure, which usually ensures airway safety and an optimal vocal outcome. However, patients with recurrent glottal papillomatosis and keratosis with dysplasia are typically monitored with various degrees of watchful waiting until there is a subjective judgment (on the part of the patient and surgeon) that the disease is more of a liability than is the procedure to treat it. Innovations in the 585-nm pulsed dye laser delivery system have allowed for its use in the clinic with local anesthesia through the working channel of a flexible fiberoptic laryngoscope. A prospective assessment was done on 51 patients in 82 cases of recurrent glottal papillomatosis (30) and dysplasia (52). All individuals had previously undergone microlaryngoscopic management with histopathologic evaluation. Five procedures could not be completed because of impaired exposure (2) or discomfort (3). Of those patients who could be treated, there was at least a 50% disease involution in 68 of 77 cases (88%) and 25% to 50% disease regression in the remaining 9 (12%). Patient self-assessment of the voice revealed that 34 of 77 were improved, 39 were unchanged, 4 were slightly worse, and none were substantially worse. These data confirm that diseased mucosa can be normalized without resection or substantial loss of vocal function. The putative mechanisms, which vary according to the fluence (energy) delivered by the laser, are photoangiolysis of sublesional microcirculation. denaturing of epithelial basement membrane linking proteins, and cellular destruction. Furthermore, this relatively safe, effective technique allowed for treatment of many patients (in a clinic setting) in whom classic surgery-related morbidity would have often delayed intervention.
Similar articles
-
Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia.Ann Otol Rhinol Laryngol. 2006 Sep;115(9):679-85. doi: 10.1177/000348940611500905. Ann Otol Rhinol Laryngol. 2006. PMID: 17044539 Clinical Trial.
-
Microlaryngoscopic and office-based injection of bevacizumab (Avastin) to enhance 532-nm pulsed KTP laser treatment of glottal papillomatosis.Ann Otol Rhinol Laryngol Suppl. 2009 Sep;201:1-13. doi: 10.1177/000348940911800901. Ann Otol Rhinol Laryngol Suppl. 2009. PMID: 19845188
-
532 nm pulsed potassium-titanyl-phosphate laser treatment of laryngeal papillomatosis under general anesthesia.Laryngoscope. 2007 Aug;117(8):1500-4. doi: 10.1097/MLG.0b013e318064e869. Laryngoscope. 2007. PMID: 17585283
-
Anesthesia management in pediatric patients with laryngeal papillomatosis undergoing suspension laryngoscopic surgery and a review of the literature.Int J Pediatr Otorhinolaryngol. 2011 Nov;75(11):1442-5. doi: 10.1016/j.ijporl.2011.08.012. Epub 2011 Sep 9. Int J Pediatr Otorhinolaryngol. 2011. PMID: 21907420 Review.
-
Office-based laryngeal laser surgery with local anesthesia.Curr Opin Otolaryngol Head Neck Surg. 2007 Jun;15(3):141-7. doi: 10.1097/MOO.0b013e3281574582. Curr Opin Otolaryngol Head Neck Surg. 2007. PMID: 17483680 Review.
Cited by
-
Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes.PLoS One. 2018 Dec 31;13(12):e0209691. doi: 10.1371/journal.pone.0209691. eCollection 2018. PLoS One. 2018. PMID: 30596718 Free PMC article.
-
Recurrent laryngeal papillomatosis: multimodal therapeutic strategies. Literature review and multicentre retrospective study.Acta Otorhinolaryngol Ital. 2023 Apr;43(Suppl. 1):S111-S122. doi: 10.14639/0392-100X-suppl.1-43-2023-14. Acta Otorhinolaryngol Ital. 2023. PMID: 37698108 Free PMC article. Review.
-
Indications, Efficacy, Safety, and Clinical Outcomes of 585 nm Pulsed Dye Laser in Non-Malignant Laryngeal Lesions: A Systematic Review.J Pers Med. 2023 Sep 14;13(9):1374. doi: 10.3390/jpm13091374. J Pers Med. 2023. PMID: 37763142 Free PMC article. Review.
-
[Laryngeal papillomatosis: etiology, diagnostics and therapy].HNO. 2008 Dec;56(12):1190-6. doi: 10.1007/s00106-008-1711-4. HNO. 2008. PMID: 19034400 Review. German.
-
Effects of 445-nm Laser on Vessels of Chick Chorioallantoic Membrane with Implications to Microlaryngeal Laser Surgery.Laryngoscope. 2021 Jun;131(6):E1950-E1956. doi: 10.1002/lary.29354. Epub 2021 Jan 18. Laryngoscope. 2021. PMID: 33459366 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources